Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3584]

ASH 2020: CAR T cell therapy effective as first-line treatment for high-risk large B-cell lymphoma

ASH 2020: CAR T cell therapy effective as first-line treatment for high-risk large B-cell lymphoma

ASH 2020: New treatment uncovered for AL amyloidosis

ASH 2020: New treatment uncovered for AL amyloidosis

ASH 2020: Chemotherapy and blinatumomab improves survival for patients with B-cell acute lymphoblastic leukaemia

ASH 2020: Chemotherapy and blinatumomab improves survival for patients with B-cell acute lymphoblastic leukaemia

ASH 2020: CRISPR-edited CAR T cells enhance fight against blood cancers

ASH 2020: CRISPR-edited CAR T cells enhance fight against blood cancers

Potential cancer therapy may boost immune response

Potential cancer therapy may boost immune response

ASH 2020: Venetoclax added to standard treatments shows promise in high-risk myeloid blood cancers

ASH 2020: Venetoclax added to standard treatments shows promise in high-risk myeloid blood cancers

ASH 2020: CAR T-cell therapy found highly effective in patients with high-risk non-Hodgkin lymphoma

ASH 2020: CAR T-cell therapy found highly effective in patients with high-risk non-Hodgkin lymphoma

Genetically engineered T cells could lead to therapies for autoimmune diseases

Genetically engineered T cells could lead to therapies for autoimmune diseases

For people with certain BRCA mutations, activating the immune system could be promising treatment

For people with certain BRCA mutations, activating the immune system could be promising treatment

Native American ancestry associated with more mutations in EGFR gene among Latin Americans

Native American ancestry associated with more mutations in EGFR gene among Latin Americans

More from ecancer